Design, synthesis, in vitro , and in silico studies of novel isatin-hybrid hydrazones as potential triple-negative breast cancer agents
RSC Advances · 2025 · 15 (2) · 948-965
DOI: 10.1039/d4ra07650h ↗Kurz gefasst
Fachartikel in der Zeitschrift RSC Advances, 2025. Verfasst von Iqra Munir und 11 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Chemical Sciences, Bahauddin Zakariya University Multan-60800 Pakistan zahidshafiq@bzu.edu.pk. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: King Saud University.
Abstract (Originalsprache)
Recent advances in cancer therapy have been made possible by monoclonal antibodies, domain antibodies, antibody drug conjugates, etc.
Autor:innen und Institutionen
- Institute of Chemical Sciences, Bahauddin Zakariya University Multan-60800 Pakistan zahidshafiq@bzu.edu.pk.
- Department of Pharmacy, Abdul Wali Khan University Mardan KPK Pakistan aharrasi@unizwa.edu.om.
- Natural and Medical Sciences Research Centre, University of Nizwa P. O. Box 33, PC 616, Birkat Al Mauz Nizwa Sultanate of Oman.
- Department of Biological Sciences and Chemistry, University of Nizwa Oman.
- Department of Chemical and Biological Engineering, College of Engineering, Korea University 145 Anam-ro, Seongbuk-gu Seoul 02841 Republic of Korea.
- School of Pharmacy, DY Patil Deemed To Be University Navi Mumbai India.
ORCID-Profile: Suraj N Mali, Vishnu Vasanthi Radhakrishnan, Bijo Mathew, Ahmed Al-Harrasi, Muhammad Safwan Akram, Zahid Shafiq
Förderung
- King Saud University
Zitieren
APA
Munir, I., Batool, Z., Khan, F., Hussain, J., Khan, A., Mali, S. N., Radhakrishnan, V. V., Mathew, B., Almutairi, T. M., Al-Harrasi, A., Akram, M. S., & Shafiq, Z. (2025). Design, synthesis, in vitro , and in silico studies of novel isatin-hybrid hydrazones as potential triple-negative breast cancer agents. RSC Advances, 15(2), 948-965. https://doi.org/10.1039/d4ra07650h
Vancouver
Munir I, Batool Z, Khan F, Hussain J, Khan A, Mali SN, et al. Design, synthesis, in vitro , and in silico studies of novel isatin-hybrid hydrazones as potential triple-negative breast cancer agents. RSC Advances. 2025;15(2):948-965. doi:10.1039/d4ra07650h
BibTeX
@article{Munir2025,
author = {Munir, Iqra and Batool, Zahra and Khan, Faizullah and Hussain, Javid and Khan, Ajmal and Mali, Suraj N and Radhakrishnan, Vishnu Vasanthi and Mathew, Bijo and Almutairi, Tahani Mazyad and Al-Harrasi, Ahmed and Akram, Muhammad Safwan and Shafiq, Zahid},
title = {Design, synthesis, in vitro , and in silico studies of novel isatin-hybrid hydrazones as potential triple-negative breast cancer agents},
journal = {RSC Advances},
year = {2025},
volume = {15},
number = {2},
pages = {948--965},
doi = {10.1039/d4ra07650h}
}
EUVIMED